Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹76.20
Market cap: ₹19.20 Cr
Revenue (annual): ₹6.14 Cr
Net profit (annual): ₹0.51 Cr
P/E (TTM): 6.9×Sector 50.4×
Promoter holding: 50.60%-15.40% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Open Offer 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jul 2026 17:43 IST BSE

Financial Results

Colinz Laboratories Q1 FY27 Results: Net Profit ₹2.4 Cr, Up 2300.0% YoY

Colinz Laboratories Ltd reported revenue from operations of ₹1.2 Cr (-25.0% YoY) and net profit of ₹2.4 Cr (+2300.0% YoY) for Q1 FY27.

Key figure: Net profit ₹2.4 Cr · +2300.0% YoY

Open full results → Read the filing ↗

29 Apr 2026 17:32 IST BSE

Financial Results

Colinz Laboratories Q4 FY26 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY

Colinz Laboratories Ltd reported revenue from operations of ₹1.7 Cr (+13.3% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q4 FY26.

Key figure: Net profit ₹0.2 Cr · +0.0% YoY

Open full results → Read the filing ↗